401 Notes BPH (benign prostatic hyperplasia) is a prevalent syndrome in old man, about 40% men over 50 years suffered from BPH, but no definitive treatment. Pollens extracts have been reported having remarkable anti-BPH activity 1, 2) and pollens have similar constitutes, including alkanes, alkenes, fatty acids, triterpene esters triglycerides, flavones, and so on.
BPH (benign prostatic hyperplasia) is a prevalent syndrome in old man, about 40% men over 50 years suffered from BPH, but no definitive treatment. Pollens extracts have been reported having remarkable anti-BPH activity 1, 2) and pollens have similar constitutes, including alkanes, alkenes, fatty acids, triterpene esters triglycerides, flavones, and so on. 3, 4) However the anti-BPH active components of pollen remain unknown. In our screening for anti-BPH pollen, Brassica rapa pollen exhibited a notable activity for reducing the volume of prostate in rat model with BPH (pϽ0.01, compared with model). In order to clarify the active principles of Brassica rapa pollen, water, 95% (v/v) ethanol, acetone and SFE-CO 2 (supercritical CO 2 fluid extract), four extracts were screened on anti-BPH activity. The SFE-CO 2 extract exhibited the remarkable bioactivity than other solvent extracts. In the following target screening the SFE-CO 2 extract showed potent 5a-reductase and aromatase inhibiting activity. Under bioactive guidance this extract was chromatographied by gel column and afforded two new phytosterol derivatives (1, 2) and eight known compounds (3) (4) (5) (6) (7) (8) (9) (10) (Fig. 1) . The structure of new compounds was determined using chemical and spectral methods. This report describes the isolation of the constitutes of Brassica rapa pollen and determination of their structure. We also report their 5a-reductase and aromatase inhibition bioactivities.
Results and Discussion
Air-dried pollen of Brassica rapa L. was extracted with SFE-CO 2 two times. The concentrated extract was fractionated by SiO 2 c.c. (silica gel column chromatography) to afford fractions A-D. Fraction B showed potent 5a-reductase inhibition with inhibitory rate as 48.88Ϯ4.6%, fractions A and B showed potent aromatase inhibition with inhibitory rate as 79.6Ϯ6.9% and 84.0Ϯ0.1%, respectively. So the fractions A and B were successively separated by means of SiO 2 c.c. and HPLC using a reverse phase column to give two new compounds 1 and 2 along with eight known compounds 3-10. The compounds of 24-methylenecholesterol palmitate (3), cycloeucalenol (4), pollinastanol (5), 24-methylenecholesterol (6), linolenic acid (7), palmitic acid (8), monolinolein (9) and monopalmitin (10) were identified by comparing their 1 H-NMR and 13 C-NMR and MS data with those reported in literature. [5] [6] [7] [8] [9] Compound 1 was obtained as a colorless oil, and its molecular formula C 46 H 76 O 2 was established from HR-ESI-MS, which gave a pseudomolecular ion peak at m/z 681.5585 [MϩNa] ϩ . The 1 H-NMR, 13 C-NMR and distortionless enhancement by polarization transfer (DEPT) spectrum (in CDCl 3 , Table 1 ) showed the presence of a 24-methylenecholesterol moiety compared with compound 6 and a unsatu-rated fat acid moiety.
10) The 1 H-and 13 C-NMR spectral data were almost consistent with those of compound 6 except that the chemical shift of C-3 of 6 was shifted downfield by 1.25 ppm in 1 H-NMR and 2.5 ppm in 13 C-NMR, respectively. Therefore it was concluded that compound 1 is a 24-methylenecholesterol derivative possessing a fatty acid ester unit at the C-3 position and the C-3 position is the only site which can be esterificated. The HMBC spectrum shown in Fig. 2 . In order to identify the position of three double bonds (C-9Ј, 10Ј, 12Ј, 13Ј, 15Ј, 16Ј), the fatty acid part was analyzed by GC-MS after saponification and derivatization. 11) Compound 1 gave a main peak at 18.6 min, the retention time and mass fragments were both in agreement with that of methyl linolenate. So the fatty acid moiety of compound 1 was a linolenic acid. Therefore, the compound 1 was identified as 24-methylenechlolesterol linolenate.
Compound 2 was obtained as colorless oil, and the molecular was determined to be C 48 H 78 O 2 from its HR-ESI-MS. 402 Vol. 57, No. 4 C-NMR and DEPT spectrum (in CDCl 3 , Table 1 ) showed the presence of a cycloeucalenol moiety compared with compound 4 and a unsaturated fat acid moiety.
10) The 1 H-and 13 C-NMR spectral data were similar with those of compound 4 except that the chemical shift of C-3 of 4 was shifted downfield by 1.31 ppm in 1 H-NMR and 1.9 ppm in 13 C-NMR, respectively. Therefore it was concluded that compound 2 is a cycloeucalenol derivative with a fatty acid ester unit at the C-3 position and the C-3 position is the only site which can be esterificated. The HMBC spectrum shown in Fig. 2 also indicates that fatty acid esterificated at C-3. The fatty acid moiety of compound 2 was deduced as linolenic acid by the same method of compound 1. So the compound 2 was determined as cycloeucalenol linolenate.
All the compounds isolated from Brassica rapa pollen were evaluated for their in vitro 5a-reductase and aromatase inhibitory activities. Firstly, the compounds were screened at a concentration of 100 mg/ml. And then the candidate compounds with an inhibitory rate over 50% were examined at concentrate of 200 mg/ml, 100 mg/ml, 50 mg/ml, 25 mg/ml, 12.5 mg/ml to calculate their IC 50 . The results show that compounds 7 and 9 are effective for 5a-reductase inhibition with inhibitory rate as 86.9Ϯ0.80% and 64.3Ϯ0.48% at 100 mg/ ml, compounds 1-6 and 10 exhibited potent activity for aromatase inhibition with inhibitory rate as 58.5Ϯ12.3%, 61.6Ϯ5.3%, 45.9Ϯ4.6%, 56.3Ϯ0.20%, 67.6Ϯ5.7%, 64.1Ϯ 0.7% and 73.1Ϯ1.1% at 100 mg/ml, respectively; the following test show that compounds 7 and 9 have an IC 50 for 5a-reductase inhibition with values of 0.07 mM and 0.18 mM, and compounds 1-6 and 10 have an IC 50 for anti-aromatase with values of 0.26 mM, 0.22 mM, 0.13 mM, 0.45 mM, 0.03 mM and 0.10 mM, respectively (Tables 2, 3 ). We can easily come to the conclusion that linolenic acid derivatives (compounds 7, 9) have more potent 5a-reductase inhibitory activity, whereas phytosterol derivatives (compounds 1-6) have more potent aromatase inhibitory activity. The two new compounds exhibited similar aromatase inhibitory activity with other phytosterols, but as phytosterol unsaturated fatty esters the new compounds have more double bonds and are liquid at room temperature. They have different solubility and chemical polarity from phytosterol, that is essential factors for the absorption of phytosterol.
12) So compounds 1 and 2 are interesting compounds in term of their chemical structure and biological activity.
Experimental
General Experimental Procedures Optical rotations were determined with a JASCO P-1020 polarimeter. UV spectra were measured on a Shimadzu UV-2500PC UV-Vis spectrometer and ATR-FTIR spectra were recorded on a Nicolet/Nexus 670 FTIR spectrometer with a Miracle single bounce ATR accessory.
1 H-and 13 C-NMR, spectra were recorded in CDCl 3 on a Bruker DRX400 NMR spectrometer. HR-ESI-MS was obtained with a YA019 Q-Tof micro mass spectrometer, ESI-MS on ZQ4000 MAA249 and EI-MS on Autospec Premier P708 mass spectrometer. Column chromatography was carried out on silica gel (Qingdao Haiyang, 300-400 mesh), octadecyl silica (ODS) (Fuji Silesia 40 mm), HPLC column (Agilent 9.4ϫ30 mm). [1b- ether-CHCl 3 (1 : 1)] was repurified with crystal to afford compound 8 (40 mg). Fraction A3 was re-chromatographed by silica gel column [CHCl 3 ] and crystallized under Ϫ20°C to afford compound 7 (22 mg). Fraction B (42.4 g) was separated into two fractions (B1, B2) over a silica gel column eluting with CHCl 3 -MeOH (from 100 : 1 to 100 : 2). Fraction B1 (780 mg) was chromatographed on a ODS column (2.4ϫ60 cm) with EtOH-H 2 O (3 : 1) to afford compound 4 (28 mg), compound 5 (19 mg) and compound 6 (25 mg). Fraction B2 (1580 mg) was re-chromatographed on a silica gel column (2.4ϫ60 cm) eluted with CHCl 3 -MeOH (100 : 2) to afford compound 9 (208 mg), compound 10 (10 mg). C-NMR spectral data shown in Table 1 .
Determination of Fatty Acid of Compounds 1 and 2 by GC-MS
The determination of fatty acid was done by modification of previous method. 13) Compounds 1 or 2 (2.0 mg) were treated with 0.5 M methanolic NaOH solution (0.4 ml) at 65°C, 5 min later 0.5 ml of 20% (w/v) boron trifluoridemethanol solution was added. After 2 min the methylated production was extracted with n-hexane (0.2 ml) and analyzed on a Hewlett Packard HP 6890/5973 series GC-MS apparatus combined with a HP-5MS column (30 mϫ025 mmϫ0.25 mm). Helium was used as carrier gas at a flow rate of 1.0 ml/min. Samples were analyzed with the column held initially at 150°C for 5 min after injection, then increased to 300°C with 5°C/min heating ramp with 10 min hold time. The injection was performed in split mode (split ratio: 30 : 1). Detector and injector temperatures were 250°C and 310°C, respectively. Run time was 45 min. MS scan range was (m/z): 20-440 atomic mass units (AMU) under EI (electron impact) ionization (70 eV). Ion source temperature: 250°C. The fatty acid components of compounds 1 and 2 were determined by comparing their mass fragmentations with those of mass spectra from the NIST database search as well as comparison of the retention times and mass spectrums of authentic samples of linolenic acid methyl ester. 5a a-Reductase Inhibitory Activity Test The 5a-reductase assay was done by previous method. 14) Briefly the reaction mixture, in a final volume of 3.0 ml, contained liver microsomes, 150 mM testosterone in 100 ml of ethanol, 167 mM NADPH, and medium A, with or without the indicated amount of a sample in 100 ml of DMSO. The reaction was started by the addition of microsomes to the pre-heated reaction solution in a tube. After 10 min the incubation was terminated by adding 100 ml of 3 M NaOH, and then 100 ml of 1.0 mM cholesterol acetate in n-hexane were added as the internal standard for GC-MS. Forty milliliters of diethyl ether were added to extract metabolites, and the tubes were capped and shaken. The organic phase was decanted and evaporated under reduced pressure. Residue was dissolved in 100 ml ethyl acetate for GC-MS. GC-MS analyses were conducted on Agilent 6890 gas chromatograph equipped with a HP-5 (30 m by 0.25 mm; film thickness, 0.25 mm) and coupled to an Agilent 5975 mass spectrometer. The mass spectrometer was operated in the EI mode at 70 eV. Helium was used as the carrier gas with a flow rate of 1.0 ml/min. The first oven temperature was 150°C for 3 min after injection, and the temperature was then increased to 300°C at a rate of 30°C/min. The sample (1 ml) was injected into the GC at an injector temperature of 310°C. The 5a-reductase activity was measured by analyzing the extent of the conversion of testosterone to dihydrotestosterone. The 5a-reductase inhibitory activity of each sample was calculated with following equation using peak-area ratios (R=A/I.S., A represent the area of dihydrotestosterone, I.S. represent the area of internal standard, cholesterol acetate.): 5a-reductase inhibitory activity (%)ϭ(RoϪRs)/Roϫ100
Ro and Rs represent the peak-area ratios of dihydrotestosterone in the absence and presence of the sample, respectively. a-Linolenic acid was used as a positive standard. Each experiment was carried out in triplicate.
Aromatase Inhibitory Activity Test The aromatase assay was done by previous method. 15) Briefly the substrate, [1b-3 H] androstenedione was dissolved in serum-free cell culture medium. Placental microsomes were prepared as 0.1 mg/ml in a potassium phosphate buffer (67 mM, pH 7.4) containing 20% (w/v) glycerol, 0.5 mM dothiothreitol, and 0.25 M sucrose. The assay reaction mixture (225 ml), containing placental microsomes (2.5 mg), [ 3 H]androstenedione (50 nM), progesterone (10 mM), and bovineserum albumin (0.1%, w/v) in potassium phosphate (67 mM, pH 7.4), with sample solution in DMSO (final DMSO concentration 2.22%, v/v), was introduced in a 3 ml tube and pre-incubated at room temperature for 10 min; then, 25 ml of NADPH (3 mM) were added and the mixture was incubated at 37°C for 15 min. The reaction was terminated by addition of 50 ml of 20% (w/v) trichloroacetic acid, and 250 ml of the solution were transferred to another well containing the charcoal-dextran pellet. The solution was thoroughly mixed and centrifuged (1000ϫg, 5 min) to remove non-reacted substrate; an aliquot of the supernatant containing [ 3 H]H 2 O as reaction product was counted in a Beckman Coulter LS 6500 Multi-Purpose Scintillation Counter. Aromatase inhibition activity was calculated as the percentage of remaining activity from the reaction without sample. Anlumitepian was used as positive control. Analyses were carried out in triplicate. 16) 
